On April 30, 2024 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, reported that senior leadership plans to present at the following conferences (Press release, Iovance Biotherapeutics, APR 30, 2024, View Source [SID1234642465]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Chardan Annual Genetic Medicines & Cell Therapy Manufacturing Summit
Fireside Chat: April 30, 2024 at 2:30 p.m. ET
Virtual
The Citizens JMP Life Sciences Conference
Fireside Chat: May 13, 2024 at 2:00 p.m. ET
New York, NY
The live and archived webcasts will be available at View Source